Newsroom

latest news from ose
and across our portfolio

Featured News

Oxford Spinout Oxford Semantic Technologies acquired by Samsung Electronics
Oxford Spinout Oxford Semantic Technologies acquired by Samsung ElectronicsArticle links to www.oxionics.com
Oxford Ionics breaks global quantum performance records
Oxford Ionics breaks global quantum performance records
Times Commentary: Science innovation must be at the heart of government action
Times Commentary: Science innovation must be at the heart of government actionArticle links to www.beacontx.com
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene TherapiesArticle links to www.prnewswire.com
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptography
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptographyArticle links to www.globenewswire.com
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raises
Amber Therapeutics Closes $100 Million Series A - one of the largest European MedTech raisesArticle links to www.businesswire.com
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group
OSE announces groundbreaking new partnership with The Crown Estate and Pioneer Group

All News

Portfolio NewsUltromicsUltromics announces partnership to expedite development of Echo AI algorithmPortfolio NewsUltromicsCMS publishes final Clinical APC rule for Ultromics EchoGo® Heart FailurePortfolio NewsUltromicsNew Technology Add-On Payment (NTAP) for Ultromics: Advancing HFpEF DiagnosisPortfolio NewsUltromicsStudy Confirms Ultromics’ AI Can Improve HFpEF Detection Using a Single Echocardiogram ViewPortfolio NewsUltromicsUltromics granted FDA Breakthrough Device DesignationPortfolio NewsUltromicsUltromics receives FDA clearance for its breakthrough device EchoGo Heart FailurePortfolio NewsUltromicsUltromics joins FNIH partnership to transform heart failure detectionPortfolio NewsUltromicsUltromics: Wolverhampton NHS cardiologists to use new cloud technology to interpret echocardiogramsPortfolio NewsUltromicsUltromics breakthrough study shows AI is a capable of independently reading stress echocardiogramsPortfolio NewsUltromicsCaption Health and Ultromics partner to put heart disease detection and management tools in more handsPortfolio NewsUltromicsUltromics announces collaboration with Janssen to develop AI for patients with amyloidosis with cardiac involvementPortfolio NewsUltromicsUltromics raises $33 million in Series B funding to help transform cardiac disease treatmentPortfolio NewsUltromicsUltromics: EchoGo predicts cardiac-related COVID-19 mortality revealed in WASE studyPortfolio NewsUltromicsUltromics CE mark's EchoGo CorePortfolio NewsUltromicsUltromics receives FDA clearance for EchoGo Pro; a first-of-kind solution to help diagnose CAD